Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sun Drug: Sales, Profits Show Double-Digit Increases
May 28, 2001
- SSP, Nihon Tenganyaku to Jointly Research Antifungal Eye Drop
May 21, 2001
- \240,000 Necessary per Month forNursing Care: Survey Respondents
May 21, 2001
- Kissei Completes Therapeutic Nutritive Food Business Center
May 21, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 21, 2001
- Ethical Drugs Achieve 2.5% Growth in FY2000
May 21, 2001
- WORLD NEWS ON BRIEF
May 21, 2001
- Sankyo Stresses Fewer Drug Interactions for Mevalotin
May 21, 2001
- Sanofi-Synthelabo, Organon to Jointly Start PII for Pentasaccharide
May 21, 2001
- Daiichi Applies for Chronic Heart Failure as New Indication for Carvedilol
May 21, 2001
- Nippon BD to Open Lab in Advanced Medical Center in Kobe
May 21, 2001
- Dainippon Licenses Antipsychotic Blonanserin to Almirall
May 21, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
May 21, 2001
- BUSINESS NEWS IN BRIEF -1-
May 21, 2001
- PAJ New Chairman to Be Enthusiastic about Promoting Self-medication
May 21, 2001
- BUSINESS NEWS IN BRIEF -2-
May 21, 2001
- Kawachi Yakuhin Ties Up with Sun Drug
May 21, 2001
- Rituximab Recommended for Approval: CDFS
May 21, 2001
- Korosho Issues Notifications of Revision of Specifications and Test Method Guidelines
May 21, 2001
- Average Household's Healthcare Spending Down in FY2000
May 21, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…